Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Schizophrenia

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 136 articles:
HTML format
Text format



Single Articles


    January 2017
  1. NKAM I, Ramoz N, Breton F, Mallet J, et al
    Impact of DRD2/ANKK1 and COMT Polymorphisms on Attention and Cognitive Functions in Schizophrenia.
    PLoS One. 2017;12:e0170147.
    PubMed     Text format     Abstract available


  2. SRINIVASAN S, Bettella F, Hassani S, Wang Y, et al
    Probing the Association between Early Evolutionary Markers and Schizophrenia.
    PLoS One. 2017;12:e0169227.
    PubMed     Text format     Abstract available


  3. CHANG M, Womer FY, Bai C, Zhou Q, et al
    Correction: Voxel-Based Morphometry in Individuals at Genetic High Risk for Schizophrenia and Patients with Schizophrenia during Their First Episode of Psychosis.
    PLoS One. 2017;12:e0170146.
    PubMed     Text format     Abstract available


  4. ADAN A, Capella MD, Prat G, Forero DA, et al
    Executive Functioning in Men with Schizophrenia and Substance Use Disorders. Influence of Lifetime Suicide Attempts.
    PLoS One. 2017;12:e0169943.
    PubMed     Text format     Abstract available


  5. HUANG CL, Hsiao S
    The Functional Significance of Affect Recognition, Neurocognition, and Clinical Symptoms in Schizophrenia.
    PLoS One. 2017;12:e0170114.
    PubMed     Text format     Abstract available


  6. DYRVIG M, Qvist P, Lichota J, Larsen K, et al
    DNA Methylation Analysis of BRD1 Promoter Regions and the Schizophrenia rs138880 Risk Allele.
    PLoS One. 2017;12:e0170121.
    PubMed     Text format     Abstract available


  7. YEE JY, Nurjono M, Teo SR, Lee TS, et al
    GAD1 Gene Expression in Blood of Patients with First-Episode Psychosis.
    PLoS One. 2017;12:e0170805.
    PubMed     Text format     Abstract available


  8. KILIAN S, Burns JK, Seedat S, Asmal L, et al
    Factors Moderating the Relationship Between Childhood Trauma and Premorbid Adjustment in First-Episode Schizophrenia.
    PLoS One. 2017;12:e0170178.
    PubMed     Text format     Abstract available


  9. PANG L, Kennedy D, Wei Q, Lv L, et al
    Decreased Functional Connectivity of Insular Cortex in Drug Naive First Episode Schizophrenia: In Relation to Symptom Severity.
    PLoS One. 2017;12:e0167242.
    PubMed     Text format     Abstract available


  10. FORSTNER AJ, Hecker J, Hofmann A, Maaser A, et al
    Identification of shared risk loci and pathways for bipolar disorder and schizophrenia.
    PLoS One. 2017;12:e0171595.
    PubMed     Text format     Abstract available


  11. ZHOU FC, Wang CY, Ungvari GS, Ng CH, et al
    Longitudinal changes in prospective memory and their clinical correlates at 1-year follow-up in first-episode schizophrenia.
    PLoS One. 2017;12:e0172114.
    PubMed     Text format     Abstract available


  12. SAMALIN L, de Chazeron I, Belzeaux R, Llorca PM, et al
    Exploratory analysis of the French version of the beliefs about medicines questionnaire in patients with severe mental disorders: Factorial structure and reliability in specific populations of schizophrenic, bipolar and depressive patients.
    PLoS One. 2017;12:e0173267.
    PubMed     Text format     Abstract available


  13. MOHITE S, Yang F, Amin PA, Zunta-Soares G, et al
    Plasma soluble L-selectin in medicated patients with schizophrenia and healthy controls.
    PLoS One. 2017;12:e0174073.
    PubMed     Text format     Abstract available


  14. WANG WC, Lu ML, Chen VC, Ng MH, et al
    Asthma, corticosteroid use and schizophrenia: A nationwide population-based study in Taiwan.
    PLoS One. 2017;12:e0173063.
    PubMed     Text format     Abstract available


  15. GUO W, Cai Y, Zhang H, Yang Y, et al
    Association of ARHGAP18 polymorphisms with schizophrenia in the Chinese-Han population.
    PLoS One. 2017;12:e0175209.
    PubMed     Text format     Abstract available


  16. RIVOLLIER F, Chaumette B, Bendjemaa N, Chayet M, et al
    Methylomic changes in individuals with psychosis, prenatally exposed to endocrine disrupting compounds: Lessons from diethylstilbestrol.
    PLoS One. 2017;12:e0174783.
    PubMed     Text format     Abstract available


  17. ARMANDO M, Schneider M, Pontillo M, Vicari S, et al
    No age effect in the prevalence and clinical significance of ultra-high risk symptoms and criteria for psychosis in 22q11 deletion syndrome: Confirmation of the genetically driven risk for psychosis?
    PLoS One. 2017;12:e0174797.
    PubMed     Text format     Abstract available


  18. SALVADOR R, Radua J, Canales-Rodriguez EJ, Solanes A, et al
    Evaluation of machine learning algorithms and structural features for optimal MRI-based diagnostic prediction in psychosis.
    PLoS One. 2017;12:e0175683.
    PubMed     Text format     Abstract available


  19. CALETTI E, Marotta G, Del Vecchio G, Paoli RA, et al
    The metabolic basis of cognitive insight in psychosis: A positron emission tomography study.
    PLoS One. 2017;12:e0175803.
    PubMed     Text format     Abstract available


  20. HOWELL KR, Floyd K, Law AJ
    PKBgamma/AKT3 loss-of-function causes learning and memory deficits and deregulation of AKT/mTORC2 signaling: Relevance for schizophrenia.
    PLoS One. 2017;12:e0175993.
    PubMed     Text format     Abstract available


  21. KIM GW, Kim YH, Jeong GW
    Whole brain volume changes and its correlation with clinical symptom severity in patients with schizophrenia: A DARTEL-based VBM study.
    PLoS One. 2017;12:e0177251.
    PubMed     Text format     Abstract available


  22. LIU H, Li L, Shen L, Wang X, et al
    Cavum septum pellucidum and first-episode psychosis: A meta-analysis.
    PLoS One. 2017;12:e0177715.
    PubMed     Text format     Abstract available


  23. RANDALL J, Chateau D, Bolton JM, Smith M, et al
    Increasing medication adherence and income assistance access for first-episode psychosis patients.
    PLoS One. 2017;12:e0179089.
    PubMed     Text format     Abstract available


  24. CONTRERAS F, Albacete A, Tebe C, Benejam B, et al
    Patients with schizophrenia activate behavioural intentions facilitated by counterfactual reasoning.
    PLoS One. 2017;12:e0178860.
    PubMed     Text format     Abstract available


  25. CHEN WY, Chen LY, Liu HC, Wu CS, et al
    Antipsychotic medications and stroke in schizophrenia: A case-crossover study.
    PLoS One. 2017;12:e0179424.
    PubMed     Text format     Abstract available


  26. YU Y, Liu ZW, Tang BW, Zhao M, et al
    Reported family burden of schizophrenia patients in rural China.
    PLoS One. 2017;12:e0179425.
    PubMed     Text format     Abstract available


  27. SQUARCINA L, Bellani M, Rossetti MG, Perlini C, et al
    Similar white matter changes in schizophrenia and bipolar disorder: A tract-based spatial statistics study.
    PLoS One. 2017;12:e0178089.
    PubMed     Text format     Abstract available


  28. BENOIT L, Moro MR, Falissard B, Henckes N, et al
    Psychosis risk research versus daily prognosis uncertainties: A qualitative study of French youth psychiatrists' attitudes toward predictive practices.
    PLoS One. 2017;12:e0179849.
    PubMed     Text format     Abstract available


  29. GIACOPUZZI E, Gennarelli M, Minelli A, Gardella R, et al
    Exome sequencing in schizophrenic patients with high levels of homozygosity identifies novel and extremely rare mutations in the GABA/glutamatergic pathways.
    PLoS One. 2017;12:e0182778.
    PubMed     Text format     Abstract available


  30. ATKINSON RJ, Fulham WR, Michie PT, Ward PB, et al
    Electrophysiological, cognitive and clinical profiles of at-risk mental state: The longitudinal Minds in Transition (MinT) study.
    PLoS One. 2017;12:e0171657.
    PubMed     Text format     Abstract available


  31. TOYOMAKI A, Hashimoto N, Kako Y, Murohashi H, et al
    Neural responses to feedback information produced by self-generated or other-generated decision-making and their impairment in schizophrenia.
    PLoS One. 2017;12:e0183792.
    PubMed     Text format     Abstract available


  32. PINHEIRO DS, Santos RDS, de Brito RB, Cruz AHDS, et al
    GSTM1/GSTT1 double-null genotype increases risk of treatment-resistant schizophrenia: A genetic association study in Brazilian patients.
    PLoS One. 2017;12:e0183812.
    PubMed     Text format     Abstract available


  33. POTKIN SG, Loze JY, Forray C, Baker RA, et al
    Relationship between response to aripiprazole once-monthly and paliperidone palmitate on work readiness and functioning in schizophrenia: A post-hoc analysis of the QUALIFY study.
    PLoS One. 2017;12:e0183475.
    PubMed     Text format     Abstract available


  34. PRIES LK, Guloksuz S, Menne-Lothmann C, Decoster J, et al
    White noise speech illusion and psychosis expression: An experimental investigation of psychosis liability.
    PLoS One. 2017;12:e0183695.
    PubMed     Text format     Abstract available


  35. SETIEN-SUERO E, Neergaard K, Ramirez-Bonilla M, Correa-Ghisays P, et al
    Cannabis use in male and female first episode of non-affective psychosis patients: Long-term clinical, neuropsychological and functional differences.
    PLoS One. 2017;12:e0183613.
    PubMed     Text format     Abstract available


  36. HAIMOVICH JS, Venkatesh AK, Shojaee A, Coppi A, et al
    Discovery of temporal and disease association patterns in condition-specific hospital utilization rates.
    PLoS One. 2017;12:e0172049.
    PubMed     Text format     Abstract available


  37. XU FL, Ding M, Yao J, Shi ZS, et al
    Association between mitochondrial DNA variations and schizophrenia in the northern Chinese Han population.
    PLoS One. 2017;12:e0182769.
    PubMed     Text format     Abstract available


  38. AFSHARI P, Yao WD, Middleton FA
    Reduced Slc1a1 expression is associated with neuroinflammation and impaired sensorimotor gating and cognitive performance in mice: Implications for schizophrenia.
    PLoS One. 2017;12:e0183854.
    PubMed     Text format     Abstract available


  39. ZAPRUTKO T, Kopciuch D, Kus K, Merks P, et al
    Affordability of medicines in the European Union.
    PLoS One. 2017;12:e0172753.
    PubMed     Text format     Abstract available


  40. PINSONNEAULT JK, Frater JT, Kompa B, Mascarenhas R, et al
    Intronic SNP in ESR1 encoding human estrogen receptor alpha is associated with brain ESR1 mRNA isoform expression and behavioral traits.
    PLoS One. 2017;12:e0179020.
    PubMed     Text format     Abstract available


  41. SULLIVAN S, Northstone K, Gadd C, Walker J, et al
    Models to predict relapse in psychosis: A systematic review.
    PLoS One. 2017;12:e0183998.
    PubMed     Text format     Abstract available


  42. DE CASTRO-CATALA M, Mora-Solano A, Kwapil TR, Cristobal-Narvaez P, et al
    The genome-wide associated candidate gene ZNF804A and psychosis-proneness: Evidence of sex-modulated association.
    PLoS One. 2017;12:e0185072.
    PubMed     Text format     Abstract available


  43. DECUYPERE F, Sermon J, Geerts P, Denee TR, et al
    Treatment continuation of four long-acting antipsychotic medications in the Netherlands and Belgium: A retrospective database study.
    PLoS One. 2017;12:e0179049.
    PubMed     Text format     Abstract available


  44. ERMAKOV EA, Smirnova LP, Bokhan NA, Semke AV, et al
    Catalase activity of IgG antibodies from the sera of healthy donors and patients with schizophrenia.
    PLoS One. 2017;12:e0183867.
    PubMed     Text format     Abstract available


  45. NAPOLITANO F, Booth Warren E, Migliarini S, Punzo D, et al
    Decreased Rhes mRNA levels in the brain of patients with Parkinson's disease and MPTP-treated macaques.
    PLoS One. 2017;12:e0181677.
    PubMed     Text format     Abstract available


  46. KANTOJARVI K, Liuhanen J, Saarenpaa-Heikkila O, Satomaa AL, et al
    Variants in calcium voltage-gated channel subunit Alpha1 C-gene (CACNA1C) are associated with sleep latency in infants.
    PLoS One. 2017;12:e0180652.
    PubMed     Text format     Abstract available


  47. WU Q, Luo X, Chen S, Qi C, et al
    Mental health literacy survey of non-mental health professionals in six general hospitals in Hunan Province of China.
    PLoS One. 2017;12:e0180327.
    PubMed     Text format     Abstract available


  48. DVEY-AHARON Z, Fogelson N, Peled A, Intrator N, et al
    Connectivity maps based analysis of EEG for the advanced diagnosis of schizophrenia attributes.
    PLoS One. 2017;12:e0185852.
    PubMed     Text format     Abstract available


  49. LEE H, Kim J
    Load-sensitive impairment of working memory for biological motion in schizophrenia.
    PLoS One. 2017;12:e0186498.
    PubMed     Text format     Abstract available


  50. JAKOBSEN AS, Speyer H, Norgaard HCB, Karlsen M, et al
    Effect of lifestyle coaching versus care coordination versus treatment as usual in people with severe mental illness and overweight: Two-years follow-up of the randomized CHANGE trial.
    PLoS One. 2017;12:e0185881.
    PubMed     Text format     Abstract available


  51. ABDIN E, Chong SA, Vaingankar JA, Peh CX, et al
    Trajectories of positive, negative and general psychopathology symptoms in first episode psychosis and their relationship with functioning over a 2-year follow-up period.
    PLoS One. 2017;12:e0187141.
    PubMed     Text format     Abstract available


  52. HUNG YY, Chan HY, Pan YJ
    Risk factors for readmission in schizophrenia patients following involuntary admission.
    PLoS One. 2017;12:e0186768.
    PubMed     Text format     Abstract available


  53. DEANE AR, Millar J, Bilkey DK, Ward RD, et al
    Maternal immune activation in rats produces temporal perception impairments in adult offspring analogous to those observed in schizophrenia.
    PLoS One. 2017;12:e0187719.
    PubMed     Text format     Abstract available


  54. MAGGIONI E, Crespo-Facorro B, Nenadic I, Benedetti F, et al
    Common and distinct structural features of schizophrenia and bipolar disorder: The European Network on Psychosis, Affective disorders and Cognitive Trajectory (ENPACT) study.
    PLoS One. 2017;12:e0188000.
    PubMed     Text format     Abstract available


  55. SHIMIZU N, Umemura T, Matsunaga M, Hirai T, et al
    An interactive sports video game as an intervention for rehabilitation of community-living patients with schizophrenia: A controlled, single-blind, crossover study.
    PLoS One. 2017;12:e0187480.
    PubMed     Text format     Abstract available



  56. Correction: Relationship between response to aripiprazole once-monthly and paliperidone palmitate on work readiness and functioning in schizophrenia: A post-hoc analysis of the QUALIFY study.
    PLoS One. 2017;12:e0188416.
    PubMed     Text format     Abstract available


  57. OLEJARCZYK E, Jernajczyk W
    Graph-based analysis of brain connectivity in schizophrenia.
    PLoS One. 2017;12:e0188629.
    PubMed     Text format     Abstract available


  58. MORERA-FUMERO AL, Diaz-Mesa E, Abreu-Gonzalez P, Fernandez-Lopez L, et al
    A three-month longitudinal study of changes in day/night serum total antioxidant capacity in paranoid schizophrenia.
    PLoS One. 2017;12:e0189348.
    PubMed     Text format     Abstract available


    January 2016
  59. SMITH RC, Amiaz R, Si TM, Maayan L, et al
    Varenicline Effects on Smoking, Cognition, and Psychiatric Symptoms in Schizophrenia: A Double-Blind Randomized Trial.
    PLoS One. 2016;11:e0143490.
    PubMed     Text format     Abstract available


  60. FENG Y, Cheng D, Zhang C, Li Y, et al
    Association of PDE4B Polymorphisms with Susceptibility to Schizophrenia: A Meta-Analysis of Case-Control Studies.
    PLoS One. 2016;11:e0147092.
    PubMed     Text format     Abstract available


  61. ZHANG Y, Hodgson NW, Trivedi MS, Abdolmaleky HM, et al
    Decreased Brain Levels of Vitamin B12 in Aging, Autism and Schizophrenia.
    PLoS One. 2016;11:e0146797.
    PubMed     Text format     Abstract available


  62. YUE Y, Kong L, Wang J, Li C, et al
    Regional Abnormality of Grey Matter in Schizophrenia: Effect from the Illness or Treatment?
    PLoS One. 2016;11:e0147204.
    PubMed     Text format     Abstract available


  63. GAO L, Hu H, Zhao FL, Li SC, et al
    Can the Direct Medical Cost of Chronic Disease Be Transferred across Different Countries? Using Cost-of-Illness Studies on Type 2 Diabetes, Epilepsy and Schizophrenia as Examples.
    PLoS One. 2016;11:e0147169.
    PubMed     Text format     Abstract available


  64. LU ML, Wu YX, Chen CH, Kuo PT, et al
    Application of Plasma Levels of Olanzapine and N-Desmethyl-Olanzapine to Monitor Clinical Efficacy in Patients with Schizophrenia.
    PLoS One. 2016;11:e0148539.
    PubMed     Text format     Abstract available


  65. DAVIS KN, Tao R, Li C, Gao Y, et al
    GAD2 Alternative Transcripts in the Human Prefrontal Cortex, and in Schizophrenia and Affective Disorders.
    PLoS One. 2016;11:e0148558.
    PubMed     Text format     Abstract available


  66. CONTRERAS F, Albacete A, Castellvi P, Cano A, et al
    Counterfactual Reasoning Deficits in Schizophrenia Patients.
    PLoS One. 2016;11:e0148440.
    PubMed     Text format     Abstract available


  67. NEBEL RA, Zhao D, Pedrosa E, Kirschen J, et al
    Reduced CYFIP1 in Human Neural Progenitors Results in Dysregulation of Schizophrenia and Epilepsy Gene Networks.
    PLoS One. 2016;11:e0148039.
    PubMed     Text format     Abstract available


  68. SUJITHA SP, Kumar DT, Doss CG, Aavula K, et al
    DNA Repair Gene (XRCC1) Polymorphism (Arg399Gln) Associated with Schizophrenia in South Indian Population: A Genotypic and Molecular Dynamics Study.
    PLoS One. 2016;11:e0147348.
    PubMed     Text format     Abstract available


  69. OMER S, Golden E, Priebe S
    Exploring the Mechanisms of a Patient-Centred Assessment with a Solution Focused Approach (DIALOG+) in the Community Treatment of Patients with Psychosis: A Process Evaluation within a Cluster-Randomised Controlled Trial.
    PLoS One. 2016;11:e0148415.
    PubMed     Text format     Abstract available


  70. SOLE-PADULLES C, Castro-Fornieles J, de la Serna E, Romero S, et al
    Altered Cortico-Striatal Connectivity in Offspring of Schizophrenia Patients Relative to Offspring of Bipolar Patients and Controls.
    PLoS One. 2016;11:e0148045.
    PubMed     Text format     Abstract available


  71. HSU WY, Lin CL, Kao CH
    A Population-Based Cohort Study on Peripheral Arterial Disease in Patients with Schizophrenia.
    PLoS One. 2016;11:e0148759.
    PubMed     Text format     Abstract available


  72. BERGER GE, Smesny S, Schafer MR, Milleit B, et al
    Niacin Skin Sensitivity Is Increased in Adolescents at Ultra-High Risk for Psychosis.
    PLoS One. 2016;11:e0148429.
    PubMed     Text format     Abstract available


  73. TSUNEYAMA N, Suzuki Y, Sawamura K, Sugai T, et al
    Effect of Serum Leptin on Weight Gain Induced by Olanzapine in Female Patients with Schizophrenia.
    PLoS One. 2016;11:e0149518.
    PubMed     Text format     Abstract available


  74. EACK SM, Wojtalik JA, Barb SM, Newhill CE, et al
    Fronto-Limbic Brain Dysfunction during the Regulation of Emotion in Schizophrenia.
    PLoS One. 2016;11:e0149297.
    PubMed     Text format     Abstract available


  75. HAMAIE Y, Ohmuro N, Katsura M, Obara C, et al
    Criticism and Depression among the Caregivers of At-Risk Mental State and First-Episode Psychosis Patients.
    PLoS One. 2016;11:e0149875.
    PubMed     Text format     Abstract available


  76. YAMASAKI S, Ando S, Shimodera S, Endo K, et al
    The Recognition of Mental Illness, Schizophrenia Identification, and Help-Seeking from Friends in Late Adolescence.
    PLoS One. 2016;11:e0151298.
    PubMed     Text format     Abstract available


  77. LIU YL, Wang SC, Hwu HG, Fann CS, et al
    Haplotypes of the D-Amino Acid Oxidase Gene Are Significantly Associated with Schizophrenia and Its Neurocognitive Deficits.
    PLoS One. 2016;11:e0150435.
    PubMed     Text format     Abstract available


  78. MILLER RL, Yaesoubi M, Turner JA, Mathalon D, et al
    Higher Dimensional Meta-State Analysis Reveals Reduced Resting fMRI Connectivity Dynamism in Schizophrenia Patients.
    PLoS One. 2016;11:e0149849.
    PubMed     Text format     Abstract available


  79. MOONS T, De Hert M, Gellens E, Gielen L, et al
    Genetic Evaluation of Schizophrenia Using the Illumina HumanExome Chip.
    PLoS One. 2016;11:e0150464.
    PubMed     Text format     Abstract available


  80. ISHIZUKA K, Kimura H, Wang C, Xing J, et al
    Investigation of Rare Single-Nucleotide PCDH15 Variants in Schizophrenia and Autism Spectrum Disorders.
    PLoS One. 2016;11:e0153224.
    PubMed     Text format     Abstract available


  81. YAMAMURO K, Kimoto S, Iida J, Kishimoto N, et al
    Reduced Prefrontal Cortex Hemodynamic Response in Adults with Methamphetamine Induced Psychosis: Relevance for Impulsivity.
    PLoS One. 2016;11:e0152373.
    PubMed     Text format     Abstract available


  82. ALBRECHT MA, Waltz JA, Cavanagh JF, Frank MJ, et al
    Reduction of Pavlovian Bias in Schizophrenia: Enhanced Effects in Clozapine-Administered Patients.
    PLoS One. 2016;11:e0152781.
    PubMed     Text format     Abstract available


  83. SOLESVIK M, Joa I, Larsen TK, Langeveld J, et al
    Visual Hallucinations in First-Episode Psychosis: Association with Childhood Trauma.
    PLoS One. 2016;11:e0153458.
    PubMed     Text format     Abstract available


  84. ZHAO G, Denisova K, Sehatpour P, Long J, et al
    Fractal Dimension Analysis of Subcortical Gray Matter Structures in Schizophrenia.
    PLoS One. 2016;11:e0155415.
    PubMed     Text format     Abstract available


  85. SHIN YS, Kim SN, Shin NY, Jung WH, et al
    Correction: Increased Intra-Individual Variability of Cognitive Processing in Subjects at Risk Mental State and Schizophrenia Patients.
    PLoS One. 2016;11:e0155573.
    PubMed     Text format     Abstract available


  86. HAMAIE Y, Ohmuro N, Katsura M, Obara C, et al
    Correction: Criticism and Depression among the Caregivers of At-Risk Mental State and First-Episode Psychosis Patients.
    PLoS One. 2016;11:e0156590.
    PubMed     Text format     Abstract available


  87. BORKOWSKA M, Millar JK, Price DJ
    Altered Disrupted-in-Schizophrenia-1 Function Affects the Development of Cortical Parvalbumin Interneurons by an Indirect Mechanism.
    PLoS One. 2016;11:e0156082.
    PubMed     Text format     Abstract available


  88. FERNANDEZ-EGEA E, Vertes PE, Flint SM, Turner L, et al
    Peripheral Immune Cell Populations Associated with Cognitive Deficits and Negative Symptoms of Treatment-Resistant Schizophrenia.
    PLoS One. 2016;11:e0155631.
    PubMed     Text format     Abstract available


  89. DEVI THAKOOR JP, Dong H, Zhang X, Wang G, et al
    Duration of Untreated Psychosis in Chinese and Mauritian: Impact of Clinical Characteristics and Patients' and Families' Perspectives on Psychosis.
    PLoS One. 2016;11:e0157083.
    PubMed     Text format     Abstract available


  90. ECKART N, Song Q, Yang R, Wang R, et al
    Functional Characterization of Schizophrenia-Associated Variation in CACNA1C.
    PLoS One. 2016;11:e0157086.
    PubMed     Text format     Abstract available


  91. VAN DER LEE A, de Haan L, Beekman A
    Schizophrenia in the Netherlands: Continuity of Care with Better Quality of Care for Less Medical Costs.
    PLoS One. 2016;11:e0157150.
    PubMed     Text format     Abstract available


  92. VAN DIJKE A, van 't Wout M, Ford JD, Aleman A, et al
    Deficits in Degraded Facial Affect Labeling in Schizophrenia and Borderline Personality Disorder.
    PLoS One. 2016;11:e0154145.
    PubMed     Text format     Abstract available


  93. ZHENG W, Cao XL, Ungvari GS, Xiang YQ, et al
    Electroconvulsive Therapy Added to Non-Clozapine Antipsychotic Medication for Treatment Resistant Schizophrenia: Meta-Analysis of Randomized Controlled Trials.
    PLoS One. 2016;11:e0156510.
    PubMed     Text format     Abstract available


  94. TENG YL, Chen CL, Lou SZ, Wang WT, et al
    Postural Stability of Patients with Schizophrenia during Challenging Sensory Conditions: Implication of Sensory Integration for Postural Control.
    PLoS One. 2016;11:e0158219.
    PubMed     Text format     Abstract available


  95. UNO K, Kikuchi Y, Iwata M, Uehara T, et al
    Decreased DNA Methylation in the Shati/Nat8l Promoter in Both Patients with Schizophrenia and a Methamphetamine-Induced Murine Model of Schizophrenia-Like Phenotype.
    PLoS One. 2016;11:e0157959.
    PubMed     Text format     Abstract available


  96. HIRJAK D, Hochlehnert A, Thomann PA, Kubera KM, et al
    Evidence for Distinguishable Treatment Costs among Paranoid Schizophrenia and Schizoaffective Disorder.
    PLoS One. 2016;11:e0157635.
    PubMed     Text format     Abstract available


  97. SONE D, Matsuda H, Ota M, Maikusa N, et al
    Graph Theoretical Analysis of Structural Neuroimaging in Temporal Lobe Epilepsy with and without Psychosis.
    PLoS One. 2016;11:e0158728.
    PubMed     Text format     Abstract available


  98. CHOI JW, Jang KM, Jung KY, Kim MS, et al
    Reduced Theta-Band Power and Phase Synchrony during Explicit Verbal Memory Tasks in Female, Non-Clinical Individuals with Schizotypal Traits.
    PLoS One. 2016;11:e0148272.
    PubMed     Text format     Abstract available


  99. KIM HJ, Koh HY
    Impaired Reality Testing in Mice Lacking Phospholipase Cbeta1: Observed by Persistent Representation-Mediated Taste Aversion.
    PLoS One. 2016;11:e0146376.
    PubMed     Text format     Abstract available


  100. NISHINAKA H, Nakane J, Nagata T, Imai A, et al
    Neuropsychological Impairment and Its Association with Violence Risk in Japanese Forensic Psychiatric Patients: A Case-Control Study.
    PLoS One. 2016;11:e0148354.
    PubMed     Text format     Abstract available


  101. YANG G, Xu H, Zhang H, Yu Q, et al
    Association between PLA2G12A Polymorphisms and Schizophrenia in a Han Chinese Population from Northeast China.
    PLoS One. 2016;11:e0159584.
    PubMed     Text format     Abstract available


  102. CATALAN A, Gonzalez de Artaza M, Bustamante S, Orgaz P, et al
    Differences in Facial Emotion Recognition between First Episode Psychosis, Borderline Personality Disorder and Healthy Controls.
    PLoS One. 2016;11:e0160056.
    PubMed     Text format     Abstract available


  103. BRISTOW LJ, Easton AE, Li YW, Sivarao DV, et al
    The Novel, Nicotinic Alpha7 Receptor Partial Agonist, BMS-933043, Improves Cognition and Sensory Processing in Preclinical Models of Schizophrenia.
    PLoS One. 2016;11:e0159996.
    PubMed     Text format     Abstract available


  104. WANG B, Franklin JM, Eddings W, Landon J, et al
    Did FDA Decisionmaking Affect Anti-Psychotic Drug Prescribing in Children?: A Time-Trend Analysis.
    PLoS One. 2016;11:e0152195.
    PubMed     Text format     Abstract available


  105. ZHUO C, Liu M, Wang L, Tian H, et al
    Diffusion Tensor MR Imaging Evaluation of Callosal Abnormalities in Schizophrenia: A Meta-Analysis.
    PLoS One. 2016;11:e0161406.
    PubMed     Text format     Abstract available


  106. HANI Y, Ghuloum S, Mahfoud Z, Opler M, et al
    Validation of the Arabic Version of Calgary Depression Scale for Schizophrenia.
    PLoS One. 2016;11:e0162304.
    PubMed     Text format     Abstract available


  107. CHEN CH
    Development of a Melting Curve-Based Allele-Specific PCR of Apolipoprotein E (APOE) Genotyping Method for Genomic DNA, Guthrie Blood Spot, and Whole Blood.
    PLoS One. 2016;11:e0153593.
    PubMed     Text format     Abstract available


  108. ZHUO C, Ma X, Qu H, Wang L, et al
    Schizophrenia Patients Demonstrate Both Inter-Voxel Level and Intra-Voxel Level White Matter Alterations.
    PLoS One. 2016;11:e0162656.
    PubMed     Text format     Abstract available


  109. LIU HC, Yang SY, Liao YT, Chen CC, et al
    Antipsychotic Medications and Risk of Acute Coronary Syndrome in Schizophrenia: A Nested Case-Control Study.
    PLoS One. 2016;11:e0163533.
    PubMed     Text format     Abstract available


  110. TROTTA A, Iyegbe C, Di Forti M, Sham PC, et al
    Interplay between Schizophrenia Polygenic Risk Score and Childhood Adversity in First-Presentation Psychotic Disorder: A Pilot Study.
    PLoS One. 2016;11:e0163319.
    PubMed     Text format     Abstract available


  111. BAK M, Drukker M, Hasmi L, van Os J, et al
    An n=1 Clinical Network Analysis of Symptoms and Treatment in Psychosis.
    PLoS One. 2016;11:e0162811.
    PubMed     Text format     Abstract available


  112. ALMEIDA OP, McCaul K, Hankey GJ, Yeap BB, et al
    Affective Disorders, Psychosis and Dementia in a Community Sample of Older Men with and without Parkinson's Disease.
    PLoS One. 2016;11:e0163781.
    PubMed     Text format     Abstract available



  113. Correction: Fractal Dimension Analysis of Subcortical Gray Matter Structures in Schizophrenia.
    PLoS One. 2016;11:e0164910.
    PubMed     Text format     Abstract available


  114. CHANG M, Womer FY, Bai C, Zhou Q, et al
    Voxel-Based Morphometry in Individuals at Genetic High Risk for Schizophrenia and Patients with Schizophrenia during Their First Episode of Psychosis.
    PLoS One. 2016;11:e0163749.
    PubMed     Text format     Abstract available


  115. BAK M, Drukker M, Hasmi L, van Os J, et al
    Correction: An n=1 Clinical Network Analysis of Symptoms and Treatment in Psychosis.
    PLoS One. 2016;11:e0165762.
    PubMed     Text format     Abstract available


  116. DOGAN BULUT S, Bulut S, Gorkem Atalan D, Berkol T, et al
    The Relationship between Symptom Severity and Low Vitamin D Levels in Patients with Schizophrenia.
    PLoS One. 2016;11:e0165284.
    PubMed     Text format     Abstract available


  117. HORSSELENBERG EM, van Busschbach JT, Aleman A, Pijnenborg GH, et al
    Self-Stigma and Its Relationship with Victimization, Psychotic Symptoms and Self-Esteem among People with Schizophrenia Spectrum Disorders.
    PLoS One. 2016;11:e0149763.
    PubMed     Text format     Abstract available


  118. LEE J, Horan WP, Wynn JK, Green MF, et al
    Neural Correlates of Belief and Emotion Attribution in Schizophrenia.
    PLoS One. 2016;11:e0165546.
    PubMed     Text format     Abstract available


  119. SUGAI T, Suzuki Y, Yamazaki M, Shimoda K, et al
    High Prevalence of Obesity, Hypertension, Hyperlipidemia, and Diabetes Mellitus in Japanese Outpatients with Schizophrenia: A Nationwide Survey.
    PLoS One. 2016;11:e0166429.
    PubMed     Text format     Abstract available


  120. POREMSKI D, Sagayadevan VD, Wang P, Lum A, et al
    The Impact of Stakeholder Preferences on Service User Adherence to Treatments for Schizophrenia and Metabolic Comorbidities.
    PLoS One. 2016;11:e0166171.
    PubMed     Text format     Abstract available


  121. ANDA L, Bronnick KS, Johnsen E, Kroken RA, et al
    The Course of Neurocognitive Changes in Acute Psychosis: Relation to Symptomatic Improvement.
    PLoS One. 2016;11:e0167390.
    PubMed     Text format     Abstract available


  122. CHIU CC, Lu ML, Huang MC, Chen PY, et al
    Effects of Low Dose Metformin on Metabolic Traits in Clozapine-Treated Schizophrenia Patients: An Exploratory Twelve-Week Randomized, Double-Blind, Placebo-Controlled Study.
    PLoS One. 2016;11:e0168347.
    PubMed     Text format     Abstract available


  123. SOKOLOWSKI M, Wasserman J, Wasserman D
    Rare CNVs in Suicide Attempt include Schizophrenia-Associated Loci and Neurodevelopmental Genes: A Pilot Genome-Wide and Family-Based Study.
    PLoS One. 2016;11:e0168531.
    PubMed     Text format     Abstract available


  124. DEL BENE VA, Foxe JJ, Ross LA, Krakowski MI, et al
    Neuroanatomical Abnormalities in Violent Individuals with and without a Diagnosis of Schizophrenia.
    PLoS One. 2016;11:e0168100.
    PubMed     Text format     Abstract available


  125. CORLEY SM, Tsai SY, Wilkins MR, Shannon Weickert C, et al
    Transcriptomic Analysis Shows Decreased Cortical Expression of NR4A1, NR4A2 and RXRB in Schizophrenia and Provides Evidence for Nuclear Receptor Dysregulation.
    PLoS One. 2016;11:e0166944.
    PubMed     Text format     Abstract available


  126. SISKIND DJ, Leung J, Russell AW, Wysoczanski D, et al
    Metformin for Clozapine Associated Obesity: A Systematic Review and Meta-Analysis.
    PLoS One. 2016;11:e0156208.
    PubMed     Text format     Abstract available


    January 2015
  127. SUGAWARA N, Ishioka M, Tsuchimine S, Tsuruga K, et al
    Attitudes toward Placebo-Controlled Clinical Trials of Patients with Schizophrenia in Japan.
    PLoS One. 2015;10:e0143356.
    PubMed     Text format     Abstract available


  128. ESCOTT-PRICE V, Kirov G, Rees E, Isles AR, et al
    No Evidence for Enrichment in Schizophrenia for Common Allelic Associations at Imprinted Loci.
    PLoS One. 2015;10:e0144172.
    PubMed     Text format     Abstract available


  129. HORVATH G, Kekesi G, Petrovszki Z, Benedek G, et al
    Abnormal Motor Activity and Thermoregulation in a Schizophrenia Rat Model for Translational Science.
    PLoS One. 2015;10:e0143751.
    PubMed     Text format     Abstract available


  130. ASHER L, Fekadu A, Hanlon C, Mideksa G, et al
    Development of a Community-Based Rehabilitation Intervention for People with Schizophrenia in Ethiopia.
    PLoS One. 2015;10:e0143572.
    PubMed     Text format     Abstract available


  131. SO SH, Tang V, Leung PW
    Dimensions of Delusions and Attribution Biases along the Continuum of Psychosis.
    PLoS One. 2015;10:e0144558.
    PubMed     Text format     Abstract available


  132. ZHANG Z, Yu H, Jiang S, Liao J, et al
    Evidence for Association of Cell Adhesion Molecules Pathway and NLGN1 Polymorphisms with Schizophrenia in Chinese Han Population.
    PLoS One. 2015;10:e0144719.
    PubMed     Text format     Abstract available


  133. PEETERS SC, van de Ven V, Gronenschild EH, Patel AX, et al
    Default mode network connectivity as a function of familial and environmental risk for psychotic disorder.
    PLoS One. 2015;10:e0120030.
    PubMed     Text format     Abstract available


  134. XU X, Xie S, Shi X, Lv J, et al
    Hexanucleotide Repeat Expansion in C9ORF72 Is Not Detected in the Treatment-Resistant Schizophrenia Patients of Chinese Han.
    PLoS One. 2015;10:e0145347.
    PubMed     Text format     Abstract available


  135. KUPPER Z, Ramseyer F, Hoffmann H, Tschacher W, et al
    Nonverbal Synchrony in Social Interactions of Patients with Schizophrenia Indicates Socio-Communicative Deficits.
    PLoS One. 2015;10:e0145882.
    PubMed     Text format     Abstract available


  136. CAMMAERTS S, Strazisar M, Smets B, Weckhuysen S, et al
    Schizophrenia-Associated MIR204 Regulates Noncoding RNAs and Affects Neurotransmitter and Ion Channel Gene Sets.
    PLoS One. 2015;10:e0144428.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: